A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors

NCT00217152 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Roche decided to prematurely terminate study.

Conditions

Kidney Transplantation
Delayed Graft Function

Interventions

DRUG: CellCept

Sponsor

Mayo Clinic

Collaborators

[object Object]